Deep Learning Improves Diagnostic Accuracy for Skin Diseases
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 16, 2024 -- Deep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.
Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatologists and 459 primary care physicians, which assessed the accuracy of diagnoses submitted by physicians in a store-and-forward teledermatology simulation. Physicians were asked to submit up to four differential diagnoses for 364 images spanning 46 skin diseases.
The researchers found that the diagnostic accuracies were 38 and 19 percent, respectively, for specialists and generalists. For diagnosis of images of dark versus light skin, both specialists and generalists were 4 percentage points less accurate. The diagnostic accuracy of both specialists and generalists was improved by more than 33 percent with fair deep learning system decision support; the gap in diagnostic accuracy of generalists was exacerbated across skin tones.
"This study allows us to see not only how artificial intelligence assistance influences, but how it influences across levels of expertise," Groh said in a statement. "What might be going on there is that the primary care physicians don't have as much experience, so they don't know if they should rule a disease out or not because they aren't as deep into the details of how different skin diseases might look on different shades of skin."
One author disclosed ties to the biotechnology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With Eczema
FRIDAY, May 31, 2024 -- Long-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD)...
Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa
THURSDAY, May 30, 2024 -- Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published...
Tattoos May Increase Risk of Malignant Lymphoma
WEDNESDAY, May 29, 2024 -- Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the June issue...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.